Moreover, in our present study, new target drugs that may address the current situation of temozolomide resistance in the treatment of glioma were screened based on SLC11A1 expression, and clofarabine and AZD8830 may be potential options for further basic research and clinical strategy development in the future. The gene discussed is SLC11A1; the disease is glioma.